Category: pharmacological
Aliases: Vfend
Second-gen triazole; extended-spectrum antifungal (Aspergillus, Fusarium, Scedosporium). Strong CYP2C19 + CYP2C9 + CYP3A4 inhibitor. CYP2C19 polymorphism drives extreme exposure variability — TDM strongly recommended. Visual disturbances (~30%) at therapeutic levels.
PO: 6h